|
|
|
|
 |
|  =Subscribers Only |
|
ONLINE FEATURES
Book Reviews
BW Video
Columnists
Interactive Gallery
Newsletters
Past Covers
Philanthropy
Podcasts
Special Reports
BLOGS
Auto Beat
Bangalore Tigers
Blogspotting
Brand New Day
Byte of the Apple
Economics Unbound
Eye on Asia
Fine On Media
Green Biz
Hot Property
Investing Insights
Management IQ
NEXT: Innovation
NussbaumOnDesign
Tech Beat
Working Parents
TECHNOLOGY
J.D. Power Ratings
Product Reviews
Tech Stats
Wildstrom: Tech Maven
AUTOS
Home Page
Auto Reviews
Classic Cars
Car Care & Safety
Hybrids
INNOVATION
& DESIGN Home Page Architecture Brand Equity Auto Design Game Room SMALLBIZ Smart Answers Success Stories Today's Tip INVESTING Investing: Europe Annual Reports BW 50 S&P Picks & Pans Stock Screeners Free S&P Stock Report SCOREBOARDS Hot Growth 100 Mutual Funds Info Tech 100 S&P 500 B-SCHOOLS Undergrad Programs MBA Blogs MBA Profiles MBA Rankings Who's Hiring Grads |
|
 DECEMBER 3, 2007 — NEWS ANALYSIS Girls Dominate the Siemens Competition For the first time in the prestigious national math and science contest's nine-year history, girls were awarded both grand prizes DECEMBER 3, 2007 — NEWS ANALYSIS Girls Dominate the Siemens Competition For the first time in the prestigious national math and science contest's nine-year history, girls were awarded both grand prizes NOVEMBER 19, 2007 — WHAT'S NEXT -- SCIENCE A Plastic with Hues You Can Use NOVEMBER 5, 2007 — WHAT'S NEXT -- SCIENCE Saving Energy By Fighting Friction Here's the rub: Resistance alone may burn as much as one-third of the world's power OCTOBER 1, 2007 — SCIENCE & TECHNOLOGY A Dream Team Of Drugs And Diagnosis? If a deal is struck, a Roche-Ventana team could help launch a medical revolution SEPTEMBER 12, 2007 — SCIENCE & TECHNOLOGY Actos Bests Avandia in New Study GlaxoSmithKline's diabetes drug Avandia faces renewed reports of cardiac risks, while Takeda's Actos appears to reduce such risks SEPTEMBER 3, 2007 — SCIENCE & TECHNOLOGY Texas Instruments: Processing Away The Pain Health-care innovations are coming from an unexpected source: Texas Instruments SEPTEMBER 3, 2007 — SCIENCE & TECHNOLOGY The Big Problem With Big Fish Feeble inspections make it easy for importers to slip through high-mercury seafood AUGUST 13, 2007 — SCIENCE & TECHNOLOGY Putting Drug Ads Back In The Bottle Efforts to curb consumer advertising are growing, but so far have met little success JULY 30, 2007 — SCIENCE & TECHNOLOGY Pressure for Provenge Approval A prostate cancer patient group files suit, demanding an FDA green light of Dendreon's vaccine. Investors are on board, too JUNE 13, 2007 — SCIENCE & TECHNOLOGY A Gender Gap in Cancer The progress against prostate cancer greatly lags breast cancer research and treatment options JUNE 13, 2007 — SCIENCE & TECHNOLOGY The Sorry States of Health Care A state-by-state study shows who has the best and worst grades on 32 health indicators, and even the best are none too good JUNE 5, 2007 — SCIENCE & TECHNOLOGY The Next Wave of Cancer Drugs There's a buzz among doctors and researchers about new inhibitor drugs that target a tumor's resistance to primary cancer treatments JUNE 4, 2007 — SCIENCE & TECHNOLOGY Is This Really The Next Big Thing? Ultrafast lasers have enormous promise--if more commercial uses can be unlocked JUNE 3, 2007 — SCIENCE & TECHNOLOGY Same Cancer Drugs, New Applications At the American Society of Clinical Oncology gathering, the talk isn't of the brand new, but of expanded uses for current treatments MAY 21, 2007 — SCIENCE & TECHNOLOGY A Shot At Making Drugs Safer Congress could revamp the cozy ties between drugmakers and the FDA. Will it? APRIL 23, 2007 — SCIENCE & TECHNOLOGY Vioxx Casts A Long, Long Shadow APRIL 23, 2007 — SCIENCE & TECHNOLOGY Under The Weather At J&J Three big products have seen setbacks, with little in sight to replace them APRIL 16, 2007 — SCIENCE & TECHNOLOGY Big Pharma's Animal Spirits Sales of medicine for pets and livestock are giving drugmakers a welcome boost APRIL 9, 2007 — SCIENCE & TECHNOLOGY Fleeing Biotechs? Not So Fast Investors are nervous about generic drugs coming to biotech. They shouldn't be  View Next Page | | |
|
Copyright by The McGraw-Hill Companies Inc. All rights reserved.